ArticleJournal of fish diseases2025
Cytotoxicity and Antiparasitic Effects of Toltrazuril Against Enteromyxum leei in Olive Flounders: In Vitro and In Vivo Analyses.
Article in Journal of fish diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The parasite Enteromyxum leei causes serious emaciation disease in marine fish species. Toltrazuril exhibits antiparasitic effects; however, the simultaneous impacts of toltrazuril on parasites and hosts are unclear. Here, we evaluate the cytotoxicity of three commercial toltrazuril products (A, B and C) and the treatment efficacy against E. leei infections in olive flounder (Paralichthys olivaceus). Product A was confirmed safe in Hirame natural embryo cells, even at a toltrazuril concentration of 50 μg/mL, and was selected for further studies. In vitro assays revealed that toltrazuril effectively killed E. leei spores at concentrations of 5.0, 7.5 and 10.0 μg/mL. In vivo experiments on olive flounders infected with E. leei showed that oral toltrazuril administration at doses of 10 and 20 mg/kg body weight for 5 days effectively damaged spores in the fish intestine, with E. leei death confirmed by propidium iodide staining. Administering toltrazuril mixed feed (20 mg/kg) to infected olive flounders in a fish-farm setting also proved effective in killing spores present in the intestine. Furthermore, Hoechst-propidium iodide double staining confirmed that toltrazuril was effective in killing E. leei spores both in vitro and in vivo, indicating its potential as a treatment for emaciation diseases in marine fish.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.